# Intertek

Global Compliance — In vitro toxicology.

Source: https://cn.bioecon.ru/companies/intertek/
Updated: 2026-07-02

- 国家: United Kingdom

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 生产基地 | 英国曼彻斯特及英国剑桥Melbourn（制药服务） | https://www.intertek.com/news/2025/intertek-expands-pharmaceutical-services-laboratory-to-enhance-capabilities-in-inhaled-biologics-and-accelerate-drug-development/, https://www.intertek.com/pharmaceutical/manchester/ |
| 认证 | 符合GLP、GCP与GMP的实验室（曼彻斯特） | https://cms.mhra.gov.uk/index.php/mhra/gmp/uk-gmp-31047-insp-gmpimp-31047343945-0017-h, https://www.intertek.com/pharmaceutical/manchester/ |
| 监管批准 | 经英国MHRA检查并批准符合GLP与GMP（人用与兽用药品）；持有Human Tissue Authority许可 | https://cms.mhra.gov.uk/index.php/mhra/gmp/uk-gmp-31047-insp-gmpimp-31047343945-0017-h, https://www.intertek.com/pharmaceutical/manchester/ |
| 员工人数 | 全球45,425名员工（截至2025-12-31） | https://w3inte.intertek.com/siteassets/investors/2026/ara/intertek-financial-report-2025.pdf |
| 营收 | 英镑34.316亿（截至2025-12-31财年） | https://w3inte.intertek.com/siteassets/investors/2026/ara/intertek-financial-report-2025.pdf, https://w3inte.intertek.com/siteassets/investors/2026/ara/intertek-strategic-report-2025.pdf |

独立来源: cms.mhra.gov.uk

## 技术

- [健康声称科学证实（EFSA第13/14条）](https://cn.bioecon.ru/technology/health-claim-substantiation-efsa/)
- [多辖区生物产品注册](https://cn.bioecon.ru/technology/multi-jurisdictional-bio-product-registration/)
- [感官评价小组](https://cn.bioecon.ru/technology/sensory-evaluation-panels/)
- [新食品批准即服务（欧盟/英国/新加坡）](https://cn.bioecon.ru/technology/novel-food-approval-as-a-service-eu-uk-sg/)
- [生物化学品REACH合规](https://cn.bioecon.ru/technology/reach-compliance-bio-chemicals/)
- [经销商合规审计（GDP）](https://cn.bioecon.ru/technology/distributor-compliance-auditing/)
